Concepedia

Publication | Open Access

Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells

35

Citations

54

References

2022

Year

Abstract

These results suggest that targeting the tumor-specific fibronectin splice variant EDA with CAR-T cells is feasible and offers a therapeutic option that is applicable to different types of cancer.

References

YearCitations

Page 1